Dana dhuwit perusahaan: Petros Pharmaceuticals, Inc. (PTPI)

Logo perusahaan publik petrospharma.com (PTPI)

Changes in cash and cash equivalents clearly demonstrate liquidity dynamics, where the 0.00 mark serves as a key metric. Stable pharmacy sales are supported by the habits of patients monetizing men's health products. This reinforces the pricing power of Stendra amid low demand elasticity. Currently, Petros Pharmaceuticals (PTPI) is executing a strategic pivot, developing IT services to transition prescription drugs into the over-the-counter consumer goods segment.

Petros - Sisa dhuwit perusahaan PTPI (periode 04.07.2022 - 28.06.2025)

Rincian metrik keuangan lan pasar Petros Pharmaceuticals, Inc. (PTPI)

Analisis komprehensif perusahaan:PTPI Petros Pharmaceuticals
Produk merek petrospharma.com

Petros Pharmaceuticals (PTPI) is facing a liquidity shortage as operating expenses outweigh revenue. This indicator measures the daily rate of capital depletion or accumulation, determining the issuer's financial stability. By analyzing cash flow dynamics, an investor can see the actual burn rate. While growing reserves reduce default risk, they may signal investment stagnation. The current state confirms the business's dependence on external financing.

Pesaing langsung

Dana dhuwit perusahaan Haleon (HLN)|Volume dana dhuwit perusahaan Kenvue Inc. (KVUE)|Volume dana dhuwit perusahaan VRNA (veronapharma.com)|Sisa dhuwit perusahaan MENS|LGND: Dhuwit awis perusahaan|Sisa dhuwit perusahaan AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Dhuwit awis perusahaan|Alvotech - Sisa dhuwit perusahaan|Dhuwit awis perusahaan LQDA|Galapagos Genomics (GLPG) - Aset likuid perusahaan|Volume dana dhuwit perusahaan ANIP|Dhuwit awis perusahaan Afrezza MNKD|Dana dhuwit perusahaan Amphastar AMPH|Aset likuid perusahaan Pacira BioSciences (PCRX)|ARS Corp - Volume dana dhuwit perusahaan|TBPH: Dana dhuwit perusahaan|AQST: Volume dana dhuwit perusahaan|SCPH - Aset likuid perusahaan|TECX (Tectonic) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tonix Pharmaceuticals Holding Corp. TNXP|Dana dhuwit perusahaan SXT Pharmaceuticals (SXTC)|Volume dana dhuwit perusahaan Eupraxia Pharmaceuticals Inc. (EPRX)|Dana dhuwit perusahaan BioHarvest Sciences BHST|EXOZ (Invizyne) - Total volume dana dhuwit perusahaan|ORMP: Dhuwit awis perusahaan|ENTX (Entera Bio Ltd) - Dhuwit awis lan setara dhuwit awis perusahaan|HYFT: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan QNTM|Volume dana dhuwit perusahaan FGEN|Dhuwit awis perusahaan Telomir Pharmaceuticals TELO|Volume dana dhuwit perusahaan RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Total volume dana dhuwit perusahaan|RLYB - Dana dhuwit perusahaan|LEXX (Lexaria Bioscience Corp.) - Dhuwit awis lan setara dhuwit awis perusahaan|pulmatrix.com (PULM) - Dana dhuwit perusahaan|PTHL (Pheton) - Dana dhuwit perusahaan|Dana dhuwit perusahaan Aptorum|Cadangan dhuwit perusahaan Lyra Therapeutics Inc. LYRA|Volume dana dhuwit perusahaan IBO|TNFA (TNF Pharmaceuticals, Inc.) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan cbdMD, Inc. YCBD|Sisa dhuwit perusahaan PRFX|Altamira Therapeutics Ltd. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Lipella Pharmaceuticals Inc|OPTN: Volume dana dhuwit perusahaan|Pieris - Sisa dhuwit perusahaan|Dhuwit awis perusahaan PROC|QLI: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SLRN|TFFP (TFF Pharmaceuticals Inc.) - Sisa dhuwit perusahaan